Serving US Federal and NGO clients.
Integrated services that cover planning, management, execution and analysis.
Insight on strategies and execution for long-term value to maximise success.
Global experience in all Phases of oncology drug development.
Offering solutions that combine in-house expertise and proprietary innovative technology.
Experience in cardiovascular trials supported by a global team of experts.
ICON and IBM are working together to revolutionise clinical trial feasibility and patient recruitment.
Digital solutions that increase efficiency in clinical trials by driving site performance.
Using data to design, simulate, and analyse adaptive clinical trials with ease.
The traditional clinical development model needs to change.
Understand and successfully address the complexities of adaptive trial design.
Remote monitoring and leveraging wearable devices and sensors in clinical trials.
17 - 19 April, 2018MedTech Strategist Innovation Summit
23 - 25 April, 2018Discover best practices for approaching challenges in NASH trial development
25 - 27 April, 2018Focusing on bringing rare disease therapies to patients faster
From a small team of 5 people in 1990, ICON now employs over 13,100 professionals in 38 countries.
We are committed to exceeding the quality standards demanded by our clients, patients and regulatory authorities.
Partners Making a Difference.
ICON has assembled a leadership team with extensive industry experience.